Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Vanpouille

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|February 9, 2012
Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirinChristophe Vanpouille, Andrea Lisco, Andrea Introini, et al.
AIDS (London, England)|July 7, 2026
Impact of influenza and pneumococcal vaccines on inflammatory response during suppressive antiretroviral therapyRenato Bobadilla, Tara L Tenenbaum, Christophe Vanpouille, et al.
Cell Host & Microbe|October 25, 2011
Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replicationGraciela Andrei, Andrea Lisco, Christophe Vanpouille, et al.
The Journal of Infectious Diseases|January 21, 2010
A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2Christophe Vanpouille, Andrea Lisco, Marco Derudas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2015
Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover TrialChristophe Vanpouille, Andrea Lisco, Jean-Charles Grivel, et al.
Journal of Extracellular Vesicles|July 17, 2024
HIV-1 Nef is carried on the surface of extracellular vesiclesChristophe Vanpouille, Beda Brichacek, Tatiana Pushkarsky, et al.
AIDS (London, England)|November 13, 2015
Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infectionChristophe Vanpouille, Andrea Introini, Sheldon R Morris, et al.
AIDS (London, England)|December 6, 2024
Cytokine trajectory over time in men and women with HIV on long-term antiretroviral therapyChristophe Vanpouille, Alan Wells, Victor DeGruttola, et al.
The Journal of Biological Chemistry|June 11, 2009
Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptaseEgor P Tchesnokov, Aleksandr Obikhod, Ivana Massud, et al.
Plos Pathogens|August 13, 2013
A multi-targeted drug candidate with dual anti-HIV and anti-HSV activityJan Balzarini, Graciela Andrei, Emanuela Balestra, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|February 9, 2012
Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirinChristophe Vanpouille, Andrea Lisco, Andrea Introini, et al.
AIDS (London, England)|July 7, 2026
Impact of influenza and pneumococcal vaccines on inflammatory response during suppressive antiretroviral therapyRenato Bobadilla, Tara L Tenenbaum, Christophe Vanpouille, et al.
Cell Host & Microbe|October 25, 2011
Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replicationGraciela Andrei, Andrea Lisco, Christophe Vanpouille, et al.
The Journal of Infectious Diseases|January 21, 2010
A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2Christophe Vanpouille, Andrea Lisco, Marco Derudas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2015
Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover TrialChristophe Vanpouille, Andrea Lisco, Jean-Charles Grivel, et al.
Journal of Extracellular Vesicles|July 17, 2024
HIV-1 Nef is carried on the surface of extracellular vesiclesChristophe Vanpouille, Beda Brichacek, Tatiana Pushkarsky, et al.
AIDS (London, England)|November 13, 2015
Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infectionChristophe Vanpouille, Andrea Introini, Sheldon R Morris, et al.
AIDS (London, England)|December 6, 2024
Cytokine trajectory over time in men and women with HIV on long-term antiretroviral therapyChristophe Vanpouille, Alan Wells, Victor DeGruttola, et al.
The Journal of Biological Chemistry|June 11, 2009
Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptaseEgor P Tchesnokov, Aleksandr Obikhod, Ivana Massud, et al.
Plos Pathogens|August 13, 2013
A multi-targeted drug candidate with dual anti-HIV and anti-HSV activityJan Balzarini, Graciela Andrei, Emanuela Balestra, et al.
Pageof 8